Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Heitzer Ellen |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Andaloro, S; Aigner, F; Uranitsch, S; Lax, S; Sallinger, K; El- Heliebi, A; Kühberger, S; Heitzer, E ctDNA release in nonmetastatic colorectal cancer.
EACR conference Liquid Biopsies 2024; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Poster]

 

Andaloro, S; Aigner, F; Uranitsch, S; Lax, S; Sallinger, K; El- Heliebi, A; Kühberger, S; Heitzer, E ctDNA shedding in early colorectal cancer.
Molecular Oncology Supplement: EACR 2024: Innovative Cancer Science. 2024; 18(S1):i-ii.-EACR 2024 Congress: Innovative Cancer Science; JUN 10-13, 2024; Rotterdam, THE NETHERLANDS. [Poster]
FullText

 

Balic, M; Klocker, EV; Dobrić, N; Graf, R; Pancheri, L; Suppan, C; Jost, PJ; Heitzer, E; Dandachi, N High-sensitivity detection and broad genomic profiling in HR+/HER2- breast cancer: Final comparative results using targeted single-gene and broad-panel sequencing assays.
The Journal of Liquid Biopsy Supplement: November 2024. 2024; 5(100190):-6th Annual Congress of Liquid Biopsy: “Advancing and Accelerating Access of Liquid Biopsy” (ISLB 2024); NOV 23-25, 2024; Denver, Colorado, USA. [Poster]
FullText

 

Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Kühberger, S; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A; A Liquid biopsy multi-analyte approach deciphering treatment resistance in prostate cancer supported by machine learning
EACR Liquid Biopsy; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Poster]

 

Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A; Longitudinal tracking of drug resistance in metastatic prostate cancer
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024. [Poster]

 

de Jager, VD; Giacomini, P; Fairley, J; Toledo, RDA; Patton, S; Joosse, S; Koch, C; Deans, S; Heitzer, E; Schuuring, E Reporting of molecular test results from cell-free DNA analyses: Expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA workshop
ANN ONCOL. 2024; 35: S259-S259. Doi: 10.1016/j.annonc.2024.08.120
Web of Science FullText FullText_MUG

 

Dobrić, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M ctDNA profiling of HR+/HER2-low and HR+/HER2-0 metastatic breast cancer patients.
Molecular Oncology Supplement: EACR 2024: Innovative Cancer Science. 2024; 18(S1):i-ii.-EACR 2024 Congress: Innovative Cancer Science; JUN 10-13, 2024; Rotterdam, THE NETHERLANDS. [Poster]
FullText

 

Dobrić, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients.
Proceedings of the 13th International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS). 2024; -13th International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. [Poster]

 

Fricska, A; Steurer, N; Grossmann, T; Steffan, B; Heitzer, E; Gugatschka, M; Grill, M Differential cytokine response and altered DNA methylation in vocal fold fibroblasts of Reinke's edema patients
13th International Conference on Voice Physiology and Biomechanics ; JUL 22-26, 2024; Erlangen, GERMANY. 2024. [Oral Communication]

 

Hallermayr, A; Wohlfrom, T; Steinke-Lange, V; Benet-Pagès, A; Scharf, F; Heitzer, E; Mansmann, U; Haberl, C; de Wit, M; Vogelsang, H; Rentsch, M; Holinski-Feder, E; Pickl, JMA Liquid biopsy in colorectal cancer - Beyond the targeted analysis of single variants
ONCOL RES TREAT. 2024; 47: 27-27.-36. Deutscher Krebskongress; FEB 21-24, 2024; Berlin, GERMANY. [Oral Communication]
Web of Science

 

Heitzer, E IN MEMORIAM: The liquid biopsy research of Prof. Michael Speicher
EACR Liquid Biopsies 2024; NOV, 11-14, 2024; Lyon, FRANCE. 2024. [Keynote lecture]

 

Heitzer, E Evaluation of preanalytical workflows for molecular profiling of urinary cell-free DNA in malignant diseases
6th Annual Liquid Biopsy Congress ; NOV 23-25, 2024; Denver, USA. 2024. [Oral Communication]

 

Heitzer, E Hereditäres Kolorektalkarzinom & Indikation zur genetischen Beratung
32. Jahrestagung der ABCSG ; NOV 8-9, 2024; Saalfelden, AUSTRIA. 2024. [Oral Communication]

 

Heitzer, E ctDNA analysis in prostate cancer –A novel approach for precision oncology
10th Thomas Ashworth CTC & Liquid Biopsy Symposium ; OCT 23-25, 2024; Sydney, AUSTRALIA. 2024. [Keynote lecture]

 

Heitzer, E Bridging biological cfDNA features and machine learning approaches
International Symposium of Variants in the Genome (ISV) 2024; MAY 13-15, 2024; Porto, PORTUGAL. 2024. [Oral Communication]

 

Heitzer, E ctDNA-based clinical decision making in advanced cancer
AACR Annual Meeting 2024; APR 5-10; San Diego, USA. 2024. [Oral Communication]

 

Heitzer, E State of the science in ctDNA: methodology, opportunities and limitations
TNM Annual Meeting in Geneva; MAY 1, 2024; Gevena . 2024. [Oral Communication]

 

Heitzer, E From Proof-of-Principle to Clinical Implementation
6th Annual Liquid Biopsy Congress ; NOV 23-25, 2024; Denver, USA. 2024. [Keynote lecture]

 

Heitzer, E Unveiling the Clinical Potential of ctDNA for Prostate Cancer Management
Grand Rounds; JAN 24; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Heitzer, E ctDNA – A promising biomarker for diagnosis, prognosis and prediction of response in breast cancer
Norwegian Network for Breast Cancer Research; MAR 19-21, 2024; Stavanger, NORWAY. 2024. [Keynote lecture]

 

Heitzer, E ctDNA-based clinical decision making in advanced cancer
Perkins Seminar Series; OCT 18, 2024; Perth, AUSTRALIA. 2024. [Oral Communication]

 

Heitzer, E Die Rolle der Humangenetik im Molekularen Tumorboard
Jahrestagung der Österreichische Gesellschaft für Humangenetik; SEP 27-28; Katschberg, AUSTRIA. 2024. [Oral Communication]

 

Jonas, K; Riedl, JM; Steinlechner, SM; Moik, F; Jahn, S; Hasenleitner, S; Doleschal, B; Weiss, L; Seeber, A; Rumpold, H; Winder, T; Greil, R; Höfler, G; Gerger, A; Jost, P; Heitzer, E; Low-level variants present a challenge in the clinical interpretation of liquid-biopsy-based comprehensive genomic profiling for patients with solid tumors
EACR Liquid Biopsies Conference; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Oral Communication]

 

Klocker, EV; Dobrić, N; Suppan, C; Graf, R; Foldi, J; Heitzer, E; Oesterreich, S; Lee, AV; Jost, PJ; Dandachi, N; Balic, M Comparison of lobular vs NST hormone receptor-positive metastatic breast cancer patients in early lines of treatment via comprehensive genomic profiling and whole-genome sequencing of circulating tumor DNA.
Proceedings of the San Antonio Breast Cancer Symposium 2024; Abstract Number: SESS-1277 . 2024; -San Antonio Breast Cancer Symposium 2024; DEC 10-13, 2024; San Antonio, TX; USA. [Poster]
FullText

 

Michenthaler, H; Pansy, K; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Deutsch, A; Prokesch, A; Fasting-induced transcriptional enhancer dynamics revealed with PRO-seq in adipose tissue and liver.
11th Helmholtz Diabetes Conference “Wasting Metabolism”; SEP 23-25, 2024; Munich, GERMANY;. 2024. [Poster]

 

Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
ANN ONCOL. 2024; 35: S262-S263. Doi: 10.1016/j.annonc.2024.08.130
Web of Science FullText FullText_MUG

 

Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ 122P - Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
Annals of Oncology. Abstract Book of the ESMO Congress 2024, 13-17 September 2024. . 2024; 35(S2):262-263.-ESMO 2024; SEP 13-17, 2024; Barcelona, Spain. [Poster]
FullText

 

Moser, MJ; Moser, T; Heitzer E Mathematical approaches boost circulating tumor DNA detection via fragmentomics.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Poster]

 

Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA. [Poster]
FullText

 

Moser, T; Moser, MJ; Eberhard, A; Ziegler, L; Bauernhofer, T; Heitzer E Fragmentomics in focus: how urine collection shapes liquid biopsy analysis.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Poster]

 

Moser, T; Vlachos, G; Heitzer, E Whole exome sequencing of cfDNA in metastatic prostate cancer.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024. [Oral Communication]
FullText

 

Müller, CT; Escriva Conde, M; Marco Salas, S; Sallinger K; Kühberger, S; Scheiber, M; Bonstingl, L; Pankratz, K; Gruber, M; Schuch, K; Kroneis, T; Uranitsch, S; Mitteregger, M; Aigner, F; Lax, SF; Nilsson, M; Heitzer E; El-Heliebi, A; Mapping Mutations in Space: Unraveling the Spatial Dynamics of Point Mutations in Colon Cancer
European Society for Spatial Biology; DEC 12-13, 2024; Berlin, GERMANY. 2024. [Poster]

 

Sadeghi, H; Mischinger, J; Mejia-Pedroza, RA; Heitzer, E. Assessment of ctDNA detection in localized prostate cancer using a multiomics approach
Poster presentation. 2024; -THOMAS ASHWORTH CTC & LIQUID BIOPSY SYMPOSIUM; Oct 23-25, 2024; Sydney, Australia. [Poster]

 

Sadeghi, H; Mischinger, J; Mejia-Pedroza, RA; Heitzer, E., Assessment of ctDNA detection in localized prostate cancer using a multiomics approach.
Poster Presentation. 2024; -The EACR Conference on Liquid Biopsies; Nov 12-14, 2024; Lyon, France. [Poster]

 

Spiegl, B; Lazzeri, I; Hasenleithner, S; Kircher, M; Heitzer, E Chromatin Compaction in Cancer: the Link Between Nucleosome Repeat Length and DNA Fragmentation
EACR Conference Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024. [Poster]

 

Vlachos, G; Moser, T; Eberhard, A ; Bauernhofer, T; Heitzer, E ctDNA can infer Homologous Recombination Deficiency in mCRPC patients. .
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024. [Poster]

 

Vlachos, G; Moser, T; Eberhard, A; Bauernhofer, T; Heitzer, E CTDNA-based detection of homologous recombination deficiency in MCRPC patients.
ISLB. 2024; -International Society of Liquid Biopsy; NOV 23-25, 2024; Denver, USA. [Poster]
FullText

 

Vlachos, G; Moser, T; Eberhard, A; Glaswitch, L; Blatterer, J; Bauernhofer, E; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E Non-invasive detection of homologous recombination deficiency in metastatic prostate cancer patients.
Annual Meeting. 2024; -AACR 2024; APR 5-10, 2024; San Diego, USA;. [Poster]
FullText

 

Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA. [Oral Communication]
FullText

 

Balihodzic, A; Fernandez-Hernandez, FJ; Jäger, V; Vosberg, S; Tonietto, M; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Doctoral Day of Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Dandachi, N; Graf, R; Pancheri, L; Dobric, N; Klocker, EV; Suppan, C; Jost, PJ; Heitzer, E; Balic, M Sensitive detection of circulating tumor DNA using targeted capture sequencing in advanced HR+/HER2- breast cancer patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. [Poster]
FullText

 

Dandachi, N; Graf, R; Pancheri, L; Dobric, N; Klocker, EV; Suppan, C; Jost, PJ; Heitzer, E; Balic, M A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
ANN ONCOL. 2023; 34: S1162-S1163.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN. Doi: 10.1016/j.annonc.2023.09.1289 [Poster]
Web of Science FullText FullText_MUG

 

Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
ANN ONCOL. 2023; 34: S387-S387.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN. Doi: 10.1016/j.annonc.2023.09.667 [Poster]
Web of Science FullText FullText_MUG

 

Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M. Comparison of ctDNA fraction and mutational profiles of plasma samples of HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. [Poster]
FullText

 

Eberhard, A; Moser, T; Hammer, S; Glawitsch, L; Ziegler, L; Vlachos, G; Lang, K; Lazzeri, I; Bauernhofer, T; Balic, M; Loibner, M; Heitzer, E Development of analysis workflows for urinary cell-free DNA in malignant disease
Advances in Circulating Tumor Cells - ACTC 2023; SEP 20-23, 2023; Skiathos, Greece. 2023. [Poster]
FullText

 

Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

 

Hallermayr, A; Steinke-Lange, V; Benetpagès, A; Wohlfrom, T; Scharf, F; Heitzer, E; Haberl, C; de Wit, M; Vogelsang, H; Rentsch, M; Holinski-Feder, E; Romic-Pickl, J Development of combined somatic copy number alteration and fragmentation analysis for monitoring in colorectal cancer patients using liquid biopsy
EUR J HUM GENET. 2023; 31: 558-559. [Poster]
Web of Science

 

Heitzer, E ctDNA - A promising biomarker for diagnosis prognosis and prediction of response in breast cancer
Oncologgia Diprecsisione nella neoplasia della Mammella; MAY 26, 2023; Rom, ITALY. 2023. [Keynote lecture]

 

Heitzer, E Integration of liquid biopsies into molecular tumor boards
ISMRC; MAY 2-5; Hamburg, GERMANY. 2023. [Oral Communication]

 

Heitzer, E Stellenwert der liquid biopsy in der Diagnostik und Therapie des Mammakarzinoms
Senologie 2023; SEP 9, 2023; Wien, AUSTRIA. 2023. [Oral Communication]

 

Heitzer, E Potentiale zirkulierender Tumor-DNA (ctDNA) in der onkologischen Versorgung
PRAEVENIRE Onkologie 2030; JUL 8, 2023; Virtuell. 2023. [Oral Communication]

 

Heitzer, E Integration of liquid biopsies into molecular tumor boards
MGZ LB Symposion; Jul 15, 2023; Virtuell. 2023. [Oral Communication]

 

Heitzer, E Integrating ctDNA analysis into clinical practice in prostate cancer
ACTC; Sep 20-23, 2023; Skiathos, GREECE. 2023. [Oral Communication]

 

Heitzer, E Molecular Profiling from Plasma to Inform about Actionable Targets
CCC-TRIO 2023 – New Frontiers in Translational Research and Immuno-Oncology; APR 27-28; Wien, AUSTRIA. 2023. [Oral Communication]

 

Heitzer, E Liquid Biopsy – Übersicht und Perspektive
13. Herbsttreffen AG Molekularpathologie; NOV 18, 2023; Virtuell. 2023. [Keynote lecture]

 

Heitzer, E Standardisation of liquid biopsy approaches
ESMO Congress 2023; Oct 20-25, 2023; Madrid, SPAIN. 2023. [Oral Communication]

 

Heitzer, E Molecular profiling of solid tumors by ctDNA
EACR-OECI Molecular Pathology Approach to Cancer Programme; MAR 26-28, 2023; Bergamo, ITALY. 2023. [Oral Communication]

 

Kühberger, S; Sallinger, K; Gruber, M; Kroneis, T; Uranitsch, S; Mitteregger, M; Aigner, F; Lax, S; El Heliebi, A; Heitzer, E Correlation of tumor size and -biology with the release of ctDNA in early colorectal cancer
DocDay 2023; FEB 2, 2023; Medical University of Graz, Austria. 2023. [Poster]

 

Leithner, A; Seidel, MG; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E; Kashofer, K Introducting liquid biopsy for paediatric patients into the clinical routine
Proceedings of the ESMO Sarcoma and Rare Cancers Congress 2023. 2023; -ESMO Sarcoma and Rare Cancers Congress; MAR 20-22, 2023; Lugano, SWITZERLAND. [Poster]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue.
Adipose Biology: Metabolic Buffering in an Obesogenic World; MAR 22-25, 2023; Edinburgh, UK. 2023. [Oral Communication]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue
8th International Graz Symposium on Lipid and Membrane Biology; APR 21-23, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue.
Aging across organelles; FEB 27, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue
DocDay Meduni Graz; FEB 9, 2023; Graz. 2023. [Oral Communication]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue
Enhanceropathies: Understanding enhancer function to understand human disease; OCT 17-20, 2023; Marseille, FRANCE. 2023. [Poster]

 

Michenthaler, H; Heininger, C; Moyschewitz, E; Reinisch, I; Galhuber, M; Krstic, J; Lazar, M; Heitzer, E; Prokesch, A Multi-omics in one assay: qPRO-seq to decipher chromatin and transcriptional landscapes of fasting in adipose tissue.
42nd Scientific meeting of the ELC. 2023; 46nd Annual Scientific Meeting of the European Lipoprotein Club; SEP 11-14, 2023; Tutzing, GERMANY. 2023. [Oral Communication]

 

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA. [Poster]

 

Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E. It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. [Poster]

 

Moser, T; Moser; MJ; Heitzer, E Cancer monitoring via blood.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023. [Oral Communication]

 

Moser, T; Moser, MJ; Lockhart, Brian; Guigal-Stephan, Nolwen; Speicher, MR; Heitzer, E It’s in our blood: Monitoring cancer treatment via circulating DNA fragmentomics.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023. [Poster]

 

Pantel, K; Andersen, CL; Schuuring, E; Malats, N; Heitzer, E; Vat, L; Kiernan, E; Chin, E; Barrett, C; Kapp, R; Thomas, M; Gerling, M; Reck, M; Löhr, M; Hofman, P; Hiltermann, N; Alix-Panabières, C; Smit, J; Bolisetty, M; Karasarides, M GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes
ANN ONCOL. 2023; 34: S276-S277.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN. Doi: 10.1016/j.annonc.2023.09.2960 [Poster]
Web of Science FullText FullText_MUG

 

Riedl, JM; Steinlechner, SM; Moik, F; Heitzer, E; Jahn, S; Hasenleithner, S; Doleschal, B; Weiss, L; Seeber, A; Rumpold, H; Winder, T; Greil, R; Jost, PJ; Hoefler, G; Speicher, M; Gerger, A SOUND: A phase II trial evaluating the efficacy of molecular profiling of circulating ± tumor tissue DNA for salvagetherapy matching in patients with advanced and refractory carcinoma
ANN ONCOL. 2023; 34: S1186-S1186.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN. Doi: 10.1016/j.annonc.2023.09.1349 [Poster]
Web of Science FullText FullText_MUG

 

Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thüringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E Liquid Biopsy In Paediatric Ewing Sarcoma Patients: A Pilot Study.
Abstracts of the 24th EFORT Annual Congress:#2198. 2023; -24th EFORT Annual Congress; MAY 24-26, 2023; Vienna, AUSTRIA. [Oral Communication]

 

Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E Investigating Homologous Recombination Deficiency in mCRPC through ctDNA.
ISMRC 13th International Symposium on Minimal Residual Cancer Book of Abstracts. 2023; -ISMRC 13th International Symposium on Minimal Residual Cancer; MAY 2-4, 2023;; Hamburg, GERMANY. [Poster]

 

Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E ctDNA can infer Homologous Recombination Deficiency in mCRPC patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. [Poster]

 

Dey, S; Sorger, H; Vieyra-Garcia, P; Teufelberger, A; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P STAT3/5 locus gain is a disease marker and therapeutic target in leukemic/ cutaneous T cell lymphoma
J INVEST DERMATOL. 2022; 142(12): S254-S254.
Web of Science

 

Geigl, JB; Gebhart, A; Wolf, P; Wolf, I; Schreiner, E; Wagner K; Heitzer, E; Speicher, MR; Windpassinger, C Familiäre Tumorhäufung, ein seltenes Syndrom?
Syndromtag 2022; Sept 30 -Oct 01, 2022; Graz, Austria. 2022. [Oral Communication]

 

Gerger, A; Riedl, J; Hasenleithner, SO; Höfler, G; Jahn, S; Esterl, T; Jost, PJ; Speicher, MR; Heitzer, E. Identifizierung von Tumorprädispositionen im Rahmen von klinischen ctDNA-Tests
ÖGH Jahrestagung; Sep 29, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Heitzer, E Genome-wide analysis of ctDNA for cancer monitoring and stratification
EACR Liquid Biopsy; MAY 24-26; Bergamo, ITALY. 2022. [Oral Communication]
FullText

 

Heitzer, E Tumormutationen – variable funktionelle Auswirkungen von Mutationen
Syndromtag 2022; SEP 30 - OCT 01, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Heitzer, E ctDNA – ein kommender Standard der Krebsnachsorge? Aktueller Status und Entwicklungsperspektiven
Präveniere Gipfelgespräch; MAY 10, 2022; WIEN, Austria. 2022. [Science to Public]

 

Heitzer, E ctDNA as a Predictor of Poor Response to Neoadjuvant Treatment in Breast Cancer
Circulating tumor DNA symposium; NOV 14, 2022; Copenhangen, DENMARK. 2022. [Oral Communication]

 

Heitzer, E Current and future perspectives of ctDNA in genomics-driven oncology
IFCC; JUN 26-30, 2022; Seoul, SOUTH KOREA. 2022. [Oral Communication]
FullText

 

Heitzer, E Standardization of ctDNA assays – lessons learned from Cancer-ID
Liquid Biopsy Scientific Interest Group, NIH; OCT 11, 2022; Virtuell. 2022. [Keynote lecture]

 

Heitzer, E Liquid Biopsy: Die richtige Therapie zum richtigen Zeitpunkt
Steirischer Krebstag 2022; Sep 10,2022; Graz, AUSTRIA. 2022. [Science to Public]

 

Heitzer, E Liquid biopsy diagnostics: Overview of Technologies and Applications in Cancer
European Meeting on Molecular Diagnostics October 09-11, 2024; OCT 09-11, 2022; Noordwijck, THE NETHERLANDS. 2022. [Oral Communication]
FullText

 

Krstic, J; Reinisch, I; Riahi, Z; Mihalic, Z; Galhuber, M; Grinninger, L; Klymiuk, I; Heitzer, E; Feichtinger, J; Kargl, J; Prokesch, A Sensitization of drug-resistant hepatocellular carcinoma through nutrient deprivation
Abstract book. 2022; -EMBO Workshop: The many faces of cancer evolution; MAY 20-22, 2022; Rimini, Italy. [Oral Communication]

 

Kühberger, S ; Sallinger, K; Kroneis, T; Uranitsch, S; Mitteregger, M; Aigner, F; Hubmann, M; Lax, S; El-Heliebi, A; Heitzer, E Correlation of tumor size and biology with ctDNA release in early colorectal cancer
Cost Action Turin; 2022. [Oral Communication]

 

Kühberger, S; Hammer, S ; Schuuring, E; Groen, HJM; Heitzer, E Genome-wide copy number calling from enriched sequencing data to identify clinically relevant somatic copy number alterations
DocDay; FEB 10, 2022; 2022. [Onlinepräsentation]

 

Lazzeri, I; Schimek, M; Speicher, M; Heitzer, E; Evaluation of unsupervised multi-view machine learning models for cancer subtype detection
. 2022; -DocDay; FEB 10, 2022; Graz, Austria. [Poster]

 

Moser, T; Erharter, L; Eberhard, A; Guigal-Stephan, N; Lockhart, B; Geigl, JB; Speicher, MR; Heitzer, E Evaluation of two kits for epigenetic workflows from liquid biopsies.
Servier Seedpods Day; MAY 31, 2022; Paris, FRANCE. 2022. [Poster]

 

Moser, T; Hasenleithner, SO; Waldispuehl-Geigl, J; Zhou, Q; Weber, S; Graf, R; Geigl, JB; Heitzer, E; Speicher, MR It’s in our blood: Improving cancer treatment monitoring via liquid biomarkers.
Festival of Genomics & Biodata; JAN 25-28, 2022; London, ENGLAND. 2022. [Oral Communication]

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria. [Poster]

 

Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E Ewing sarcoma and liquid biopsy: plasma ctDNA quantification by ddPCR for monitoring residual disease
21st General Meeting of the International Society of Limb Salvage; IL5. 2022; 11-11.-21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA. [Oral Communication]

 

Seidel, MG; Leithner, A; Kashofer, K; Moser, T; Theuringer, A; Liegl-Atzwanger, B; Benesch, M; Szkandera, J; El-Heliebi, A; Heitzer, E Liquid biopsy for monitoring paediatric Ewing sarcoma patients.
Abstract Book of the 34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2022; 27--34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); OCT 17-19, 2022; London, GREAT BRITAIN. [Oral Communication]

 

Dey, S; Sorger, H; Vieyra-Garcia, P; Araujo, ED; Graf, R; Spiegl, B; Schlederer, M; Graier, T; Perchthaler, I; Fink-Puches, R; Cerroni, L; Surbek, M; Pirker, C; Berger, W; Orlova, A; Herling, M; Merkel, O; Neubauer, HA; Gunning, PT; Heitzer, E; Kenner, L; Moriggl, R; Wolf, P STAT5 is a therapeutically targetable vulnerability in leukemic cutaneous T-cell lymphoma
EXP DERMATOL. 2021; 30(3):E100-E101. [Poster]
Web of Science

 

Dey, S; Sorger, H; Vieyra-Garcia, PA; de Araujo, ED; Graf, R; Spiegl, B; Lazzeri, I; Herling, M; Neubauer, HA; Merkel, O; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P Chromosome # 17q (17q11.2-17q21.31) gain is a disease marker and therapeutic vulnerability in Sezary Syndrome
EXP DERMATOL. 2021; 30: 14-14.-4th Inflammatory Skin Disease Summit; NOV 03-06, 2021; New York, NY. [Poster]
Web of Science

 

Galhuber, M; Michenthaler, H; Heininger, C; Reinisch, I; Nössing, C; Krstic, J; Kupper, N; Moyschewitz, E; Auer, M; Heitzer, E; Ulz, P; Birner-Gruenberger, R; Liesinger, L; Lenihan-Geels, GN; Oster, M; Spreitzer, E; Zenezini Chiozzi, R; Schulz, TJ; Schupp, M; Madl, T; Heck, AJR; Prokesch, A; Complementary omics strategies to dissect p53 signaling networks under nutrient stress.
Doctoral Day, Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021. [Onlinepräsentation]

 

Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]
FullText

 

Heitzer, E. Utility of Circulating Tumor DNA as a Response and Follow-Up Marker in Cancer Therapy
ESHG 2021; JUN 12-15, 2021; Virtuell. 2021. [Oral Communication]

 

Heitzer, E. Technical Evaluation Of Commercial Mutation Analysis Platforms For Liquid Biopsy Profiling
NextGen Omics 2021; NOV 4-5, 2021; London, UK (virtuell). 2021. [Oral Communication]

 

Heitzer, E. Potenzial der Liquid Biopsy für das Therapiemanagement beim NSCLC
ITOG; OKT 13, 2021; Innsbruck, AUSTRIA (virtuell). 2021. [Oral Communication]

 

Heitzer, E. The potential of ctDNA in clinical practice: From single gene to genome wide approaches
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021); SEP 22-25, 2021; Kalamata, GREECE. 2021. [Oral Communication]
FullText

 

Heitzer, E. New aspects of liquid profiling diagnostics in oncology
Medica Düsserldorf; NOV 17, 2021; Düsseldorf, GERMANY. 2021. [Oral Communication]

 

Heitzer, E. Utility of Circulating Tumor DNA as a Response and Follow-Up Marker in Cancer Therapy
ISBER; MAY 10-14, 2021; Virtuell. 2021. [Keynote lecture]

 

Heitzer, E. Technologies for the analysis of circulating DNA
ESMO Advanced Course on BIOMARKERS FOR PRECISION MEDICINE; NOV 12-13, 2021; Zurich, SWITZERLAND. 2021. [Oral Communication]

 

Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, G; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Zenezini Chiozzi, R; Grinninger, L; Feichtinger, J; Klymiuk, I; Heitzer, E; Heck, AJR; Huch, M; Malli, R; Prokesch, A Overcoming hepatocellular cancer drug resistance by targeting metabolic flexibility confered by p53
https://virtual.keystonesymposia.org/ks/. 2021; -Keystone Symposium on Hepatobiliary Cancers (EK29); March 22-24, 2021; https://virtual.keystonesymposia.org/ks/. [Oral Communication]
FullText

 

Kühberger, S; Weber, S; Graf, R; Moser, T; Spiegl, B, Hasenleithner, SO; Speicher, MR; Schuuring, E; Groen, HJM; Heitzer, E. Genomewide copy number calling from enriched sequencing data to identify clinically relevant somatic copy number alterations
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]

 

Lazzeri, I; Schimek, M; Speicher, M; Heitzer, E; Evaluation of unsupervised multi-view machine learning models for cancer subtype detection.
DocDay; FEB 12, 2021; Graz, Austria. 2021. [Poster]

 

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G, Schuuring, E; Groen, HJM; Geigl, JB; Heiter, E; Speicher, MR Harnessing circulating tumor DNA to inform clinical decisions
Festival of Genomics & Biodata 2021; JAN 26-29, 2021; London, ENGLAND. 2021. [Onlinepräsentation]

 

Pischler, C; Beichler, C; Pristauz, G; Trapp, EK; Peintinger, F; Weirather, C; Siebenhofer, C; Petru,E; Geigl, J; Heitzer, E; Speicher, M Identification of biomarkers from plasma-DNA from patients with ovarian cancer
Doctoral Day 2021; FEB 12, 2021; Virtual Congress, Graz, AUSTRIA. 2021. [Onlinepräsentation]

 

Sallinger, K; Bonstingl, L; Pritz, E; Pankratz, K; Kühberger, S; Heitzer, E; Kroneis, T; El-Heliebi, A Establishment of the in situ sequencing method to investigate the source of circulating tumor cells and circulating tumor DNA.
Advances in Circulating Tumor Cells - ACTC 2021; SEP 22-25, 2021; Kalamata, Greece. 2021. [Poster]

 

Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML, Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Groen, HJM;Heitzer, E. Dynamic changes of circulating tumor DNA predict clinical outcome in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021. [Poster]

 

Christoph Suppan, Qing Zhou, Stephan Jahn, Ricarda Graf, Eva Valentina Klocker, Angelika Terbuch, Karl Kashofer, Florian Posch, Hanno Gerritsmann, Nadia Dandachi, Ellen Heitzer, Marija Balic Comparison of liquid biopsy and tissue based detection ofPIK3CAmutations in HR positive metastatic breast cancer patients.
SABCS 2020. 2020; -SABCS 2020; DEC 8-11, 2020; SAN ANTONIO, TEXAS, USA. [Poster]

 

Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Grill, M; Lazzeri, I; Grossmann, T; Heitzer, E; Gugatschka, M Gene expression analysis using RNA sequencing reveals novel insights into pathological alterations in human vocal fold fibroblasts from patients with Reinke’s edema.
12th International Conference on Voice Physiology and Biomechanics, ICVPB; Dec 2-4, 2020; Grenoble, France. 2020. [Onlinepräsentation]

 

Heitzer, E Genome-wide analysis of ctDNA for cancer monitoring and stratification.
24th Human Genome Meeting HGM2020; APR 5-8, 2020; Perth, AUSTARLIA. 2020. [Oral Communication]
FullText

 

Heitzer, E Assessment of ctDNA workflows for clinical decision making.
EACR Liquid Biopsies; NOV, 18-19, 2020; Bergamo, ITALY. 2020. [Oral Communication]
FullText

 

Heitzer, E ctDNA in precision oncology – opportunities and challenges.
12th ISMRC; OCT, 24-25, 2020; Shanghai, CHINA. 2020. [Oral Communication]
FullText

 

Heitzer, E Gegenwart und Zukunft von Liquid Biopsies
Onkologische Wintergespräche 2020; JAN 24-25; Wien, AUSTRIA. 2020. [Keynote lecture]
FullText

 

Heitzer, E Current and future perspectives of circulating tumor DANN.
ÖGDV SCIENCE DAYS 2020; JAN 16-18, 2020; Mondsee, AUSTRIA. 2020. [Keynote lecture]
FullText

 

Heitzer, E Clinical decision making based on circulating tumour DNA.
Global Engage-Liquid Biopsies Congress; OCT, 8-9, 2020; London, UK. 2020. [Oral Communication]
FullText

 

Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A Improved sensitivity of liquid biopsies in prostate cancer: A multi-analyte approach.
EACR Liquid Biopsies Virtual Event; NOV 18-19, 2020; Nottingham, UK. 2020. [Poster]

 

Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A Another step towards personalized medicine: A multi-analyte approach for improved sensitivity of liquid biopsies in prostate cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020. [Poster]

 

Katja Sallinger; Lilli Hofmann;Thomas Kroneis; Thomas Bauernhofer; Ellen Heitzer; Amin El-Heliebi Tracking the trace: Elucidating the source of circulating tumor cells and circulating tumor DNA.
4th Annual Meeting of the ÖPPM;; 2020; Vienna, AUSTRIA. 2020. [Poster]

 

Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16): Doi: 10.1158/1538-7445.AM2020-4295 [Poster]
Web of Science FullText FullText_MUG

 

Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020. [Poster]

 

Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Liquid biopsy profiling of advanced cancer patients for clinical decision support platform analysis.
ÖGPath Frühjahrstagung 2020; SEP 11-12, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]

 

Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

Suppan, C; Zhou, Q; Graf, R; Klocker, V; Terbuch, A; Dandachi, N; Heitzer, E; Balic, M Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients.
ANN ONCOL. 2020; 31: S41-S41.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.213 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Lampignano, R; Neumann, MHD; Weber, S; Kloten; V, Herdean; A; Voss, T; Groelz, D; Babayan, A; Tibbesma, M; Schlumpberger, M; Chemi, F;. Rothwell, DG; Wikman, H; Galizzi, JP; Bergheim, IR, Russnes, H; Mussolin, B; Bonin, S; Voigt, C; Musa, H; Pinzani, P; Lianidou, E; Brady, G; Speicher, MR; Pantel, K; Betsou, F; Schuuring, E; Kubista, M; Ammerlaan, W; Sprenger-Haussels, M; Schlange; T; Heitzer, E. Multicenter evaluation of ccfDNA extraction and downstream analyses for the development of standardized (pre)analytical workflows
Advances in Circulating Tumor Cells (ACTC) 2019; SEP 2-6, 2019; Corfu, GREECE. 2019. [Oral Communication]
FullText

 

Auinger, L; Rupp, V; Foßelteder, J; Frömmel, M; Geigl, J; Reinisch, A; Heitzer, E; Speicher, M; Genetic Modelling of the BAP1 Tumour Predisposition Syndrome in Human iPSCs using an Inducible Knock-Out System
International Student Congress; MAI 31-JUNI 1, 2019; Medizinische Universität Graz. 2019. [Poster]
FullText

 

Auinger, L; Rupp, V; Foßelteder, J; Reinisch, A; Geigl, J; Heitzer, E; Speicher, M; How to Knock Out a Gene - the hard way
DocDay; NOV 21, 2019; Medizinische Universität Graz. 2019. [Poster]
FullText

 

Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

Brudzewsky, D; Lampignano, R; Weber, S; Sartori, A; Mohan, S; Konigshofer, Y; Davis, L; Rothwell, D; Schuuring, E; Garlick, RK; Schlange, T; Heitzer, E Multicenter evaluation of circulating tumor DNA assays
CANCER RES. 2019; 79(13): Doi: 10.1158/1538-7445.AM2019-438 [Poster]
Web of Science FullText FullText_MUG

 

Crnobrnja, B; Knez, J; Sobocan, M; Cas-Sikosek, N; Vogrin, V; Repnik, K; Heitzer, E; Potocnik, U; Takac, I FREE - CELL TUMOR DNA AS A BIOMARKER FOR EARLY BREAST CANCER
INT J GYNECOL CANCER. 2019; 29: A178-A178. Doi: 10.1136/ijgc-2019-ESGO.263 [Oral Communication]
Web of Science FullText FullText_MUG

 

Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

 

Dutta S, Pregartner G, Rücker FR, Heitzer H, Zebisch A, Bullinger L, Berghold A, Döhner K, Sill H Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Blood. 2019; 134, Suppl. 1: -American Society of Hematology, Annual Meeting; DEC 6-10, 2019; Orlando. [Poster]

 

DuttaS, Pregartner G, Rücker F, Heitzer E,Zebisch A, Bullinger L,Berghold A, Döhner K Sill H Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
German-Austrian Acute Myeloid Leukemia study group (AML-SG) Study meeting ; May 23-24, 2019; Vienna, Austria. 2019. [Oral Communication]

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Kupper, N; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A Hepatic p53 in adaptation to nutrient stress
Austrian Proteomics and Metabolomics Research Symposium 2019; SEPT 18-20, 2019; Salzburg, AUSTRIA. 2019. [Poster]

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Kupper, N; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A Hepatic p53 in adaptation to nutrient stress
Doctoral Day 2019, Public Presentations for Doc School and PhD Students; NOV 21, 2019; Graz, AUSTRIA. 2019. [Poster]

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Kupper, N; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A. Hepatic p53 in adaptation to nutrient stress
Conference Abstract Book. 2019; -Nature, Nature Medicine, Ageing, Health & Rejuvenation; JUN 23-26, 2019; Rotterdam, NETHERLANDS. [Poster]

 

Heitzer, E Moving beyond DNA sequence: nucleosome occupancy profiling of plasma DNA
Liquid Biopsies - Cold Spring Harbor Laboratory; SEP 8-11, 2019; The Banbury Center, Lloyd Harbor, New York. 2019. [Keynote lecture]
FullText

 

Heitzer, E; Balic, M ABCSG 34: Mutationsanalyse Primärtumore und ctDNA
ABCSG Jahestagung; NOV, 8-9; Saalfelden, AUT. 2019. [Oral Communication]

 

Heitzer, E on behalf of Cancer-ID Multicenter evaluation of ccfDNA extraction and downstream analyses for the development of standardized (pre)analytical workflows
ESHG 2019 https://2019.eshg.org/; JUN, 12-16; Gotenborg, SWEDEN. 2019. [Oral Communication]
FullText

 

Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA. [Poster]

 

Lazzeri, I; Perakis, S; Moser, T; Zhou, Q; Ulz, P; Speicher, M; Heitzer, E Building a cell type specific signature matrix for methylation based tissue deconvolution
DOCTORAL DAY 2019; NOV 20, 2019; Graz, Austria. 2019. [Poster]

 

Moser, T; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Speicher, MR; Heitzer, E Molecular profiling of circulating tumor DNA in plasma of patients with renal cancer.
30th Annual Meeting of the German Society of Humangenetics ; MAR 6-8, 2019; Weimar, GERMANY. 2019. [Poster]

 

Moser, T; Smith, CG; Mouliere, F; Chandrananda, D; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E Untargeted profiling of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, ISRAEL. 2019. [Poster]

 

Moser, T; Smith, CG; Mouliere, F; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E Non-invasive tumor profiling via circulating tumor DNA in patients with renal tumors.
Doctoral Day 2019; NOV 21, 2019; Graz, AUSTRIA. 2019. [Poster]
FullText

 

Moser, T; Smith, CG; Seles, M; Pichler, M; Wcislo, G; Eldridge, M; Mouliere, F; Heider, K; Warren, A; Rosenfeld, N; D Stewart, GD; Heitzer, E Comprehensive characterization of ctDNA in plasma and urine reveals renal cell carcinoma as a low ctDNA tumor type.
Advances in Circulating Tumor Cells (ACTC) 2019; SEP 2-6, 2019; Corfu, GREECE. 2019. [Oral Communication]
FullText

 

Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart, GD; Heitzer, E Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
CANCER RES. 2019; 79(13):-AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology; MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-1367 [Poster]
Web of Science FullText FullText_MUG

 

Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart GD; Heitzer, E Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Current Developments in Non-invasive Biomarkers for Assessment of Cancer 2. 2019; -AACR; MAR 29-APR 3, 2019; Atlanta, Georgia, USA. [Poster]

 

Pantel, K; Terstappen, LW; Manaresi, N; Groen, HJ; Schuuring, EM; Heitzer, E; Speicher, M; Naume, B; Kyte, JA; Schlange, T Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.SABCS18-3190 [Poster]
Web of Science FullText FullText_MUG

 

Perakis, S; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Höfler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment study
The Next Generation of Clinical Trials in Molecularly Driven Therapy. 2019; -AACR; MAR 29-APR 3, 2019; Atlanta, Georgia, USA. [Oral Communication]

 

Perakis, SO; Speicher, MR; Heitzer, E Moving beyond DNA sequence: genome-wide profiling of plasma DNA
31st European Congress of Pathology; SEP 7-11, 2019; Nice, France. 2019. [Oral Communication]

 

Perakis, SO; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Hoefler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment study
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-CT130 [Poster]
Web of Science FullText FullText_MUG

 

Rinner, B; Brvar, L; Brcic, I; Heitzer, E; Leithner, A; Liegl-Atzwanger, B Establishment of sarcoma cell lines.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY . [Poster]

 

Smith, CG; Moser, T; Riediger, AL; Eldridge, M; Mouliere, F; Mitchell, TJ; Warren, A; Heitzer, E; Rosenfeld, N; Stewart, GD Application of sensitive sequencing methods for comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, ISRAEL. 2019. [Poster]

 

Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019. [Poster]
FullText

 

Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Peter, U; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, WM; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL. Doi: 10.1158/1538-7445.AM2018-2959 [Oral Communication]
Web of Science FullText FullText_MUG

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Kupper, N; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A Hepatic p53 in adaptation to nutrient stress.
LIPOTOX. 2018; -International Graz Symposium on Lipid and Membrane Biology; APR 9-11; Graz, AUSTRIA. [Poster]

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Reinisch, I; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A Hepatic p53 in adaptation to nutrient stress.
Cell Symposia. 2018; -Aging and Metabolism; SEPT 23-25, 2018; Sitges, SPAIN. [Poster]

 

Galhuber, M; Madl, T; Heitzer, E; Ulz, P; Birner-Grünberger, R; Moyschewitz, E; Auer, M; Reinisch, I; Nössing, C; Knauer, M; Münzner, M; Dohr, G; Schultz, TJ; Schupp, M; Prokesch, A Hepatic p53 in adaptation to nutrient stress.
Doctoral Day. 2018; -Retrain the Brain; NOV 28; Graz, AUSTRIA. [Poster]

 

Heitzer, E Liquid Biopsy in der Diagnose und Therapie von Krebs
Volkhochschule Wien; DEZ 3, 2018; Vienna, AUSTRIA . 2018. [Science to Public]

 

Heitzer, E High resolution ctDNA analysis for monitoring response to immune therapy in NSCLC patients
Roche User Meeting; OCT 10-11, 2018; Riga, LETTLAND. 2018. [Oral Communication]

 

Heitzer, E Impact of circulating tumor DNA analysis on prognosis and therapy management in metastatic cancer patients
Thomas Ashworth Liquid Biopsy Symposium; SEP 25-28; Sydney, AUSTRALIA. 2018. [Oral Communication]

 

Heitzer, E. High resolution ctDNA analysis for monitoring response to immune therapy in NSCLC patients
European Congress of Pathology; SEP 8-12; Bilbao, SPAIN. 2018. [Oral Communication]

 

Heitzer, E. Impact of ctDNA Analysis on Prognosis and Therapy Monitoring in Metastatic Cancer
CHI Mol Diagnostics; MAY 22-23, 2018; Lisbon, Portugal. 2018. [Oral Communication]

 

Heitzer, E. Disease Monitoring bei Brustkrebs mittels ctDNA
Tagung der Sektion Molekulare Diagnostik; JUN 6-7, 2018; Tutzing. 2018. [Keynote lecture]

 

Klec, C; Resel, M; Foßelteder, J; Prinz, F; Kapeller, A; Deutsch, A; Heitzer, E; Rinner, B; Stöger, H; Graier, WF; Pichler, M Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1.
Retrain the Brain. Doctoral Day 2018. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA. [Oral Communication]

 

Kleinegger, F; Schrom, S; Thalhammer, M; Aigelsreiter, A; Haybäck, J; Heitzer, E; Rinner, B; Establishment of a New Cholangiocarcinoma Cell Line MUG-CCArly1
21st European Congress on Alternatives for Animal Testing. 2018; -EUSAAT 2018; SEP 23-26, 2018; Linz, Austria. [Oral Communication]

 

Lazzeri, I; Perakis, S; Moser, T; Zhou, Q; Ulz, P; Heitzer, E; Speicher, M Patterns of aging in diverse liquid biopsy assays
Young Investigator Retreat; 1- 4, 2018; Seeboden, AUSTRIA. 2018. [Oral Communication]

 

Moser, T; Ulz, P; Zhou, Q; Perakis, Samantha; Geigl, JB; Speicher, MR; Heitzer, E Single-stranded library preparation does not preferentially enrich circulating tumor DNA.
11th International Symposium on Minimal Residual Cancer. 2018; -ISMRC; MAY 3-5, 2018; Montpellier, FRANCE. [Poster]

 

Pabst, G; Prochazka, K; Pregartner, G; Rücker, FG; Heitzer, E; Woelfler ,A; Zebisch, A; Berghold, A; Döhner, K; Sill H. Impact of TP53 mutated subclones in acute myeloid leukemia
Blood. 2018; 132(Suppl ):-Annual Meeting of the American Society of Hematology; December 1-4, 2018; San Diego. Doi: 10.1182/blood-2018-99-110667 [Poster]
Web of Science FullText FullText_MUG

 

Suppan, C; Brcic, I; Heitzer, E; Tiran, V; Mueller, HD; Auer, M; Cote, RJ; Datar, R; Dandachi, N; Balic, M Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment
EUR J CANCER. 2018; 92: S136-S136.-11th European Breast Cancer Conference (EBCC); MAR 21-23, 2018; Barcelona, SPAIN. [Poster]
Web of Science

 

Tamminga, M; de Wit, S; Swennenhuis, JF; Heitzer, E; Speicher, M; Hiltermann, TJN; Schuuring, EM; Terstappen, LWM; Groen, HJ Circulating tumor cells measured in the pulmonary vein and radial artery during surgery of non-small cell lung cancer
CANCER RES. 2018; 78(13): Doi: 10.1158/1538-7445.AM2018-5594
Web of Science FullText FullText_MUG

 

Yang, J; Marass, F; Ulz, P; Shady, M; Cheng, ML; Kothari, P; Gedvilaite, E; Somnay, S; Shukla, N; Modak, S; Slotkin, EK; Rathkopf, DE; Gopaumar, I; Scher, HI; Razavi, P; Feldman, DR; Li, BT; Chapman, PB; Rosenberg, JE; Bajorin, DF; Scher, HI; Berger, MF; Seshan, VE; Socci, ND; Solit, DB; Heitzer, E; Tsui, DWY Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
CANCER RES. 2018; 78(13): Doi: 10.1158/1538-7445.AM2018-LB-227
Web of Science FullText FullText_MUG

 

Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Role of frequent chr13 q12.2 amplification in colorectal cancer patients
Role of frequent chr13 q12.2 amplification in colorectal cancer patients. 2018; -11th International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE. [Poster]

 

Gaksch, L; Kashofer, K; Heitzer, E; Daga, S; Hofer, S; Krisper, N; Hofler, G; Zebisch, A; Sill, H; Wolfler, A Persistence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML
ONCOL RES TREAT. 2017; 40: 140-141. [Oral Communication]
Web of Science

 

Gellner, Verena; Tomazic, Peter Valentin; Lohberger, Birgit; Meditz, Katharina; Heitzer, Ellen; Mokry, Michael; Koele, Wolfgang; Leithner, Andreas; Liegl-Atzwanger, Bernadette; Rinner, Beate Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0143. 2017; 70--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY. [Oral Communication]

 

Graier, T; Auer, M; Heitzer, E; Ulz, P; Perakis, S; Speicher, MR; Geigl, JB Rapid single-cell copy-number aberration analysis using high- throughput sequencing.
EUR J CANCER. 2017; 72: S24-S24.-ECCO European Cancer Congress; JAN 27-30, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0959-8049(17)30159-4 [Poster]
Web of Science FullText FullText_MUG

 

Heitzer, E Role of Circulating Tumor DNA In Ovarian Cancer
OVARIAN CANCER - molecular aspects in modern diagnostics and therapy ; MAY 19-20, 2017; Warsaw, POLAND. 2017. [Keynote lecture]

 

Heitzer, E Circulating tumor DNA as a liquid biopsy for cancer
MOL CYTOGENET. 2017; 10: -EUROPEAN CYTOGENETICS CONFERENCE; JUN 30 - JUL 3, 2017; Florence, ITALY. [Oral Communication]
Web of Science

 

Heitzer, E Monitoring Treatment Response and Identification of Actionable Targets from Plasma DNA
CHI Molecular Diagnostics Europe; APR 10-12, 2017; Lisbon, Portugal. 2017. [Oral Communication]

 

Heitzer, E Liquid Biopsy in der personalisierten Krebstherapie
Martinsrieder Symposium; Feb 2, 2017; Martinsried, GERMANY. 2017. [Oral Communication]

 

Heitzer, E. Pros and Cons of genomewide Profiling of cell-free circulating DNA
LKI Symposium Liquid Biopsy; AUG 27-29, 2017; Leuven, BELGIUM. 2017. [Oral Communication]

 

Heitzer, E. Liquid Profiling im Management von Tumorpatienten: Erfahrungen aus der Routinediagnostik
IGDL; MAR 3-4, 2017; Düsseldorf, GEMANY. 2017. [Oral Communication]

 

Heitzer, E. Untargeted Monitoring of Treatment Response in Metastatic Breast Cancer Patients undergoing systemic and/or HER2- targeting Treatment
Proceedings of the 10th CNPAS Meeting. 2017; -CNAPS X, 2017; SEP 22-22, 2017; Montpellier, FRANCE. [Oral Communication]

 

Heitzer, E; ,Auer, M; Suppan, C; Dandachi, N; Balic, M. Changes in ctDNA levels established with the untargeted mFAST-SeqS method reflect response to therapy in metastasized breast cancer patients
Proceedings of the 24EACR. 2017; -EACR; JUL 9-12, 2016; Manchester, UK. [Poster]
FullText

 

Heitzer, E; Ulz, P; Geigl JB; Speicher MR Circulating tumor DNA in Cancer Monitoring
European Journal of Human Genetics. 2017; -Annual Meeting ESHG; MAY 27-31, 2017; Cogenhagen, DENMARK. [Oral Communication]

 

Heizer, E Liquid Biopsies – Mammakarzinom
ÖGPath-Frühjahrstagung; Feb 23, 2017; Vienna, AUSTRIA . 2017. [Oral Communication]

 

Jelena Belic, Peter Ulz, Ellen Heitzer, Maria Smolle, Thomas Bauernhofer, Katja Fischereder, Jochen B. Geigl1, Michael R. Speicher Detection and characterization of neuroendocrine prostate cancer using whole genome-sequencing in circulating tumor DNA
3rd EACR Conference on Cancer Genomics; Jun 25-28, 2017; Cambridge, UK. 2017. [Oral Communication]
FullText

 

Moser, T; Ulz, P; Zhou, Q; Perakis, S; Geigl, JB; Speicher, MR; Heitzer, E Single-stranded library preparation does not preferentially enrich circulating tumor DNA.
Doctoral Day 2017; DEC 13, 2017; Graz, AUSTRIA. 2017. [Poster]

 

Perakis S, Zhuo Q, Weber S, Ulz P, Geigl JB, Speicher MR and Heitzer E Diagnostic workflows for liquid biopsy approaches
http://journals.sagepub.com/doi/full/10.1177/1010428317742551. 2017; -ISOBM 2017 ; SEP 4-7, 2017; Rio de Janerio, BRASIL. [Oral Communication]
FullText

 

Rupp, V; Ledam, R; Frömmel, M; Geigl, J; Wiesner, T; Ercan, E; Heitzer, E; Speicher, M Modelling the BAP1 tumor syndrome in iPSC derived melanocytes using an inducible knock-out system
Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 29, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Suppan, C; Tiran, V; Heitzer, E; Auer, M; Cote, RJ; Datar, RH; Dandachi, N; Balic, M Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis
EUR J CANCER. 2017; 72: S39-S40. Doi: 10.1016/S0959-8049(17)30211-3 [Poster]
Web of Science FullText FullText_MUG

 

Tiran, V; Lindenmann, J; Stanzer, S; Brcic, L; Heitzer, E; Ghaffari-Tabrizi, N; Fink-Neuböck, N; Popper, H; Dandachi, N; Balic, M Patient-derived Lung Adenocarcinoma Cells challenge the association of Cancer Stem Cells with Epithelial to Mesenchymal Transition.
OeGHO Frühjahrstagung; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

 

Ulz P, Perakis S, Zhuo Q, Moser T, Speicher MR and Heitzer E Nucleosome positioning as cancer biomarker
https://doi.org/10.1177/1010428317742551 . 2017; -ISOBM; SEP 4-7, 2017; Rio de Janerio, BRASIL. [Oral Communication]
FullText

 

Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR Nucleosome occupancy of cfDNA informs about gene expression
10th CNAPS International Symposium ; SEP 20-22, 2017; Montpellier, FRANCE. 2017. [Oral Communication]

 

Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR Inferring expressed genes by whole-genome sequencing of plasma DNA
28. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 29-31, 2017; Bochum, GERMANY. 2017. [Oral Communication]

 

Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR Nucleosome association of cell-free DNA informs about gene expression
8th international Gene Quantification Event Symposium & Industrial Exhibition & Application Workshops ; APR 3-7, 2017; Freising-Weihenstephan, GERMANY. 2017. [Oral Communication]

 

Zhou, Q; Perakis, S; Ulz, P; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Investigation of the role of frequent chr13 q12.2 focal amplification in colorectal cancer patients
17. Jahrestagung der Österreichischen Gesellschaft für Humangenetik (ÖGH); SEP 29, 2017; Graz, AUSTRIA . 2017. [Oral Communication]

 

Balic, M, Heitzer, E Klinische Anwendbarkeit von zirkulierender DNA
... 2016; -Combating Breast Cancer; 11.-12.11.; Duesseldorf, Germany. [Keynote lecture]

 

Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT. Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05 [Oral Communication]
Web of Science FullText FullText_MUG

 

Belic,J;Ulz,P; Graf, R; Auer, M; Fischereder, K; Hoefler, G; Bauernhofer, T, Geigl, JB; Heitzer, E; Speicher, MR Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer
Proceedings Book of the 24EACR. 2016; -EACR; JUL 9-12, 2016; Manchester, UK. [Poster]
FullText

 

Gaksch, L; Kashofer, K; Heitzer, E; Daga, S; Hofer, S; Krisper, N; Höfler, G; Zebisch, A; Sill, H; Wölfler A Persitence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML.
Oncol Res Treat 2016. 2016; 39(suppl3):140--Jahrestagung DGHO; OCT 14-18,2016; Leipzig. (ISBN: 2296-5270 ) [Oral Communication]
Web of Science

 

Hasenoehrl, C; Feuersinger, D; Graf, R; Heitzer, E; Haybaeck, J; Schuligoi, R; Schicho, R Atypical cannabinoid receptor GPR55 plays an opposing role to cannabinoid receptor 1 in colon cancer
8th Annual Meeting of the ÖGMBT; SEP 12-14, 2016; Graz, Austria. 2016. [Poster]

 

Hasenoehrl, C; Feuersinger, D; Graf, R; Heitzer, E; Haybaeck, J; Schuligoi, R; Schicho, R Differential roles of G protein-coupled receptors GPR55 and CB1 in colon cancer
Gastroenterology. 2016; 150(4):82-83.-Digestive Disease Week; MAY 21-24, 2016; San Diego, USA. [Oral Communication]

 

Heitzer, E Zirkulierende zellfreie Tumor DNA - Möglichkeiten und Grenzen einer Therapiesteuerung.
ÖGHO Jahrestagung, Salzburg; APR 23-24, 2015; Salzburg, AUSTRIA. 2016. [Oral Communication]

 

Heitzer, E Klinische Anwendbarkeit von zirkulierender Tumor DNA
Tumorgenetische Arbeitstagung; May 19-21, 2016; München, GERMANY. 2016. [Oral Communication]

 

Heitzer, E Circulating tumor DNA as a tool for minimal-invasive tumor monitoring
Fortbildung St.Anna Kinderspital ; MAR 10, 2016; Vienna, AUSTRIA . 2016. [Keynote lecture]

 

Heitzer, E Recent Technological Advances in the Analysis of ctDNA – Are we Ready for Clinical Use?
Recent Technological Advances in the Analysis of ctDNA – Are we Ready for Clinical Use; APR 4-6, 2016; Lisbon, PORTUGAL. 2016. [Oral Communication]
FullText

 

Heitzer, E. Klinische Anwendbarkeit von zirkulierender Tumor-DNA als Marker für ein Therapie Monitoring
Onkologische Wintergespräche Novartis ; DEC 15-16, 2016; Vienna, AUSTRIA . 2016. [Oral Communication]
FullText

 

Heitzer, E. Liquid Biopsies bei Gastrointestinalen Tumoren
MGZ Symposium; NOV 26, 2016; Munich, GERMANY. 2016. [Oral Communication]

 

Heitzer, E. Liquid Profiling im Management von Tumorpatieten: Erfahrungen aus der Routinediagnostik
http://www.dgkl.de/. 2016; -DKLM 2016; SEPT 28-30, 2016; Mannheim, GERMANY. [Oral Communication]

 

Heitzer, E. Therapiesteuerung bei Krebspatienten anhand von zirkulierender Tumor DNA – Realität oder Zukunftsmusik
Fortbildung MGZ, München; MAR 22, 2016; München, GERMANY. 2016. [Keynote lecture]

 

Heitzer, E; Perakis, S; Auer, M; Belic, J; Ulz, P; Lafer, I; Bauernhofer, T; Petru, E; Augustin, H; Geigl, JB; Speicher, MR. Clinical Utility of Circulating Tumor DNA Monitoring: A report of more than 400 plasma-Seqs
Medizinische Genetik. 2016; -GfH Tagung ; MAR 16-18, 2016; Lübeck, GERMANY. [Oral Communication]

 

Heitzer, E; Ulz, P; Thallinger, GG; Auer, M; Kashofer K; Jahn, SW; Abete L; Pristauz, G; Petru, E; Geigl,JB; Speicher, MR. Inferring expressed genes by whole-genome sequencing of plasma DNA.
https://ep70.eventpilot.us/web/planner.php?id=ASHG16. 2016; -ASHG 2016; OCT 18-22, 2016; vancouver Kanada. [Poster]
FullText

 

Jelena Belic, Peter Ulz, Ellen Heitzer, Martina Auer, Katja Fischereder, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher Detection of clonal shifts in metastatic prostate cancer patients using whole genome-sequencing in circulating tumor DNA
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment ; März 19-21, 2016; Hamburg, GERMANY. 2016. [Oral Communication]

 

Lal, R; Lind, K; Kashofer, K; Heitzer, E; Ulz, P; Troppmair, J; Hofer, S; Schulz, E; Mathre, K; Wölfler, A; Zebisch, A; Sill, H TP53 mutations in acute myeloid leukemia affect pre-leukemic stem cells
memo - Magazine of European Medical Oncology . 2016; 0(1):19-20.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA. [Poster]

 

Lieal-Atzwanger, B; Heitzer, E; Flicker, K; Muller, S; Ulz, P; Saglanm, O; Tavassoli, F; Devouassoux-Shisheboran, M; Cieigl, J; Moinfar, F Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumours
VIRCHOWS ARCH. .. 2016; 469: S18-S19. [Poster]
Web of Science

 

Liegl-Atzwanger, B; Heitzer, E; Flicker, K; Mueller S; Ulz, P; Soglam, O; Tavassoli, F; Devouassoux-Shisheboran, M; Geigl, J; Moinfar, F Exploring chromosonal abnormalities and genetic changes in uterine smooth muscle tumours.
Virchows . 2016; 464(1):1-346.-XXXI International Congress of the IAP and 28th Congress of the ESP; SEP 25 - 29, 2016; Cologne, Germany. [Oral Communication]

 

Smolle, MA; Pichler, M; Roßmann, C; Samonigg, H; Heitzer, E; Belic, J; Speicher, M; Pummer, K; Bauernhofer, T Neuroendocrine transdifferentiation in castration resistant metastatic prostate cancer (mCRPC) - A case series
OeGHO & AHOP Frühjahrstagung; MAR 17 - 19, 2016; Vienna, AUSTRIA. 2016. [Poster]

 

Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR; Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
16. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

 

Ulz, P; Graier, T; Auer, M; Geigl, JB; Speicher, MR; Heitzer, E Rapid copy-number aberration profiling of single-cells without whole-genome amplification
10th International Symposium on Minimal Residual Cancer; MAR 19-21, 2016; Hamburg, GERMANY. 2016. [Poster]

 

Ulz, P; Heitzer, E; Auer, M; Belic, J; Perakis, S; Geigl, JB; Speicher, MR; Krebsdiagnostik aus dem peripheren Blut: Zirkulierende Tumor DNA (ctDNA)
Forum Spital 2016, Update Onkologie; JUN 15-16, 2016; Vösendorf, AUSTRIA. 2016. [Oral Communication]

 

Ulz, P; Heitzer, E; Speicher, MR Co-occurrence of MYC amplification and TP53 mutations in human cancer
27. Jahrestagung der Deutschen Gesellschaft für Humangenetik; MAR 17-19, 2016; Lübeck, GERMANY. 2016. [Oral Communication]

 

Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR Inferring expressed genes by whole-genome sequencing of plasma DNA.
16. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

 

Zhou, Q; Perakis, S; Ulz, P; Heitzer, E; Pichler,M; Gerger, A; Bauernhofer, T; Geigl, JB; Speicher, MR Monitoring targeted therapy response by cell-free circulating tumor DNA in metastatic colorectal cancer
Doctoral day; DEC 14, 2016; Graz, Austria. 2016. [Poster]

 

Belic, J; Heitzer, E; Ulz, P ; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Analysis of ctDNA using mFastSeqS and plasma–Seq methods for screening and therapy monitoring in prostate cancer patients
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy; June 13-16, 2015; Salt Lake City, Utah, USA. 2015. [Oral Communication]
FullText

 

Belic, J; Koch, M; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Heitzer, E Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
EACR CONFERENCE SERIES 2015 2ND SPECIAL CONFERENCE: CANCER GENOMICS; 28 JUNE – 1 JULY 2015; Cambridge, UK. 2015. [Poster]
FullText

 

Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer E. mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-specific Aneuploidy in Plasma DNA
Circulating Nucleic Acids in Plasma and Serum - Proceedings. 2015; -CNAPS; SEP 10-12, 2015; Berlin, GERMANY. [Oral Communication]

 

Hasenoehrl, C; Feuersinger, D; Graf, R; Heitzer, E; Haybaeck, J; Schuligoi, R; Schicho, R The roles of opposing receptors GPR55 and CB1 in colon cancer
Abstract Booklet. 2015; -Doctoral Day of the Medical University of Graz; DEC 11, 2015; Graz, AUSTRIA. [Oral Communication]

 

Heitzer, E Neue Perspektiven des Tumormonitorings bei Prostatakarzinomen
Grand Rounds Urologie AKH; Feb 11, 2015; Vienna, Austria. 2015. [Oral Communication]

 

Heitzer, E Insights into tumor heterogeneity and progression by the analysis of circulating tumor cells
25th Annual Meeting of the German society for Cytometry; OCT 5-7, 2015; Berlin, GERMANY. 2015. [Oral Communication]

 

Heitzer, E Praxisrelevante Aspekte der Genetik für die Allgemeinmedizin
Fortbildung der Ärtzekammer ; Jan 29, 2015; Murau, AUSTRIA. 2015. [Keynote lecture]

 

Heitzer, E „Liquid biopsy - Tumorsignaturen im Blut
Onkologienetzwerk Westösterreich & Südtirol; May 21, 2015; Innsbruck, Austria. 2015. [Oral Communication]

 

Heitzer, E; Ulz, P. Plasma-Seq Workshop
CEU UGM Illumina; MAR 10-11, 2015; Heidelberg, Germany. 2015. [Keynote lecture]

 

Heitzer, E; Ulz, P; Auer, M; Belic, J; Sumitra, M; Lax, S; Hoefler, G; Augustin, H; Edgar, P; Bauernhofer, T; Geigl, J; Speicher, M Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs
EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0959-8049(16)30108-3 [Poster]
Web of Science FullText FullText_MUG

 

J. Belic, M. Koch, P. Ulz, M. Auer, K. Fischereder, T. Bauernhofer, J. B. Geigl, M. R. Speicher, E. Heitzer Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
2nd EACR Special Conference on Cancer Genomics, Churchill College; June-July 28-1, 2015; Cambridge, UK. 2015. [Poster]

 

Rupp, VM.; Hoffmann EM; Heitzer, E; Auer, M; Ulz; P, Perakis, S; Beichler, C; Geigl, JB; Speicher,MR A novel adenoviral system allows highly specific tumor cell detection in blood
Medizinische Genetik, March 2015, Volume 27, Issue 1, pp 79-196. 2015; 27(1):79-196.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz. [Oral Communication]
FullText

 

Speicher, MR; Heitzer, E; Ulz, P; Geigl, JB; Monitoring tumor evolution by whole-genome plasma sequencing
CANCER RES. 2015; 75: -106th Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 18-22, 2015; Philadelphia, PA. Doi: 10.1158/1538-7445.AM2015-SY37-02 [Oral Communication]
Web of Science FullText FullText_MUG

 

Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA. [Oral Communication]
FullText

 

Ulz, P; Heitzer, E; Belic, J; Auer, M; Geigl, JB, Speicher, MR; Analysis of cell-free DNA in metastasized cancer patients using next-generation sequencing
5th Polish Illumina Symposium; OCT 15-16, 2015; Poznan, POLAND. 2015. [Oral Communication]

 

Ulz, P; Heitzer, E; Belic, J; Lafer, I; Schwarzbraun, T; Bauernhofer, T; Eisner, F; Pichler, M; Fischereder, K; Gutschi, S; Augustin H; Pummer K; Webersinke, G; Geigl, JB; Speicher, MR; Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
15. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 25, 2015; Salzburg, AUSTRIA. 2015. [Oral Communication]

 

Auer, M; Heitzer, E; Ulz, P; Petru, E; Pristauz, G; Jahn, S; Speicher, MR; Geigl, JB Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://gfhev.de/de/kongress/GfH_Tagung_2014_Abstractbook.pdf. 2014; -25. Jahrestagung der Deutschen Gesellschaft für Humangenetik; MARCH 19-21, 2014; Essen, GERMANY. [Poster]

 

Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl JB Low coverage whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://eacr23.eacr.org/. 2014; -23rd Biennal Congress of the European Association of Cancer Research; JULY 4 - 8, 2014; Munich, GERMANY. [Poster]

 

Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl, JB; Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer.
EUR J CANCER. 2014; 50: S153-S153.-EACR; München. Doi: 10.1016/S0959-8049(14)50562-X [Oral Communication]
Web of Science FullText FullText_MUG

 

Heitzer, E Tracking Tumor-specific Changes from Plasma
Bastion Workshop Warschau 2014; OCT 28, 2014; Warsaw, POLAND. 2014. [Keynote lecture]

 

Heitzer, E Liquid Biopsies - neue Perspektiven in der nicht-invasiven Tumoranalytik
ÖGH Tagung 2014; SEP 26, 2014; Linz, AUSTRIA. 2014. [Keynote lecture]

 

Heitzer, E Tracking tumor-specific changes from plasma
CEU UGM Illumina Mai 2014; May 5, 2014; Heidelberg, GERMANY. 2014. [Keynote lecture]

 

Heitzer, E Tracking Tumor-specific Changes from Plasma
TechTalk Vortragsreihe der Abteilung Core Facilities Genomics and Proteomics DKFZ ; SEP 15, 2014; DKFZ Heidelberg. 2014. [Keynote lecture]

 

Heitzer, E, Heidary, M; Auer, M; Ulz, P; Petru, P; Gasch, C; Riethdorf, S; Mauermann, O; Lafer, I; Pristauz, G; Lax, S; Pantel, K; Geigl, JB; Speicher, M.R Divergence between high metastatic tumor burden and low circulating tumor DNA concentration in metastasized breast cancer
26. Jahrestagung der GfH; MAR, 19-21, 2014; Essen, GERMANY. 2014. [Oral Communication]

 

Heitzer, E; Mohan, S; Ulz, P; Lafer, I; Auer, M; Lax, S; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR; Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München. Doi: 10.1016/S0959-8049(14)50357-7 [Poster]
Web of Science FullText FullText_MUG

 

Heitzer, E; Palles, C; Ulz, P; Speicher, M.R; Kearsey, S;Tomlinson, I Functional analysis of mutations in polymerase epsilon gene that predispose to polymerase proofreading associated polyposis (PPAP)
26. Jahrestagung der GfH; MAR, 19-21, 2014; Essen, GERMANY. 2014. [Poster]

 

Heitzer, E; Palles, C; Ulz, P; Speicher, M.R; Kearsey, S;Tomlinson, I Functional analysis of mutations in polymerase epsilon gene that predispose to polymerase proofreading associated polyposis (PPAP)
http://www.ashg.org/2014meeting/pages/abstracts.shtml. 2014; -ASHG 2014; OCT 18-22, 2014; San Diego, USA. [Poster]

 

Auer, M; Fondi, M; Heitzer, E; Pristauz, G; Petru, E; Jahn, S; Gasch, C; Pantel, K; Riethdorf, S; Speicher, MR; Geigl, JB High-resolution molecular characterization of circulating cell-free DNA and circulating tumor cells of patients with metastatic breast cancer
7. Forschungsforum der österreichsichen Fachhochschulen; APRIL 3-4, 2013; Dornbirn, AUSTRIA. 2013. [Poster]

 

Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Riethdorf, S; Speicher, MR; Geigl, JB Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing.
http://www.ecco-org.eu. 2013; -The European Cancer Congress 2013 (ECCO17 - ESMO38 - ESTRO32) ; SEP 27 - OCT 1, 2013; Amsterdam, NETHERLANDS. [Keynote lecture]

 

Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Speicher, MR; Geigl, JB Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing
EUR J CANCER. 2013; 49: S399-S399.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Auer, M; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Gasch, C; Riethdorf, S; Pantel, K; Geigl, JB; Speicher, MR; Heitzer, E High-resolution molecular characterization of circulating cell-free DNA and circulating tumor cells of patients with metastatic breast cancer.
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY. [Keynote lecture]

 

Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR Analysis of plasma DNA using whole genome sequencing in patients with prostate cancer
Gordon Research Seminar & Conference; July, 7-12,2013; RI, USA. 2013. [Oral Communication]

 

Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR Whole genome plasma DNA sequencing as a non-invasive tool for personalized therapy in prostate cancer patients
EMBL Conference, Cancer Genomix; Nov 3-5, 2013; Heidelberg, Germany. 2013. [Oral Communication]

 

Geigl, JB; Pristauz, G; Ulz, P; Lafer, I; Högenauer, C; Petru, E; Speicher, MR; Heitzer, E Li-Fraumeni Syndrome and Hereditary Diffuse Gastric Cancer in one patient identified by next generation sequencing
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY. [Poster]

 

Heitzer E, Mach M, Filipits M, Balic M, Resel M, Graf R, Weißenbacher B, Lax S, Heitzer, E; Mach, M; Filipits, M; Balic, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Samonigg, H; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Schaberl-Moser, R; Dandachi, N. Methylation of PCDH10, SPARC, and UCHL1 predicts survival and in stage II colorectal cancer patients.
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY. [Poster]

 

Heitzer, E; Ulz, P; Belic, J; Gutschi, S; Quehenberger, F; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR Tumor associated copy number changes identified by whole-genome sequencing in the circulation of patients with prostate cancer
EUR J CANCER. 2013; 49: S98-S98.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Mohan, S; Heitzer,E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler,M; Eisner,F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR; Development of acquired resistance to anti-EGFR therapy in colorectal cancer identified by whole-genome plasma DNA sequencing
Doctoral Day; Dec 9, 2013; Graz. 2013. [Poster]

 

Belic, J; Auer, M; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Ulz, P; Geigl, J; Augustin, H; Eisner, F; Höfler, G; Pantel, K; Riethdorf, S; Geigl, JB; Speicher, MR Characterization of circulating tumor cells and plasma DNA in patients with prostate cancer
Doctoral day; dec 7,2012; Graz, Austria. 2012. [Poster]

 

Geigl JB; Heitzer E; Wolf I; Lax S; Cerroni L; Speicher MR SUFU germline mutation in a patient with Gorlin syndrome identified by next generation sequencing.
62nd Annual Meeting of The American Society of Human Genetics; Nov 6-10, 2012; San Francisco, USA. 2012. [Poster]

 

Heidary, M; Heitzer, E; Geigl, JB; Speicher, MR. Characterization of CTCs with Stem Cell Features from Patients with Breast Cancer.
Doctoral day 2012 ; Graz, AUSTRIA. 2012. [Poster]

 

Heitzer, E; Auer, M; Hoffmann, EM; Beneken, C; Pichler, M; Lax, S; Ulz, P; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Complex tumor genomes inferred from plasma-DNA and circulating tumor cells of patients with colorectal cancer.
Human Genetics Conference 2012; JUNE 23 - 27; Nürnberg, GERMANY. 2012. [Oral Communication]
FullText

 

Heitzer, E; Marija, B; Resel, M; Graf, R; Weissenbacher, B; Schaberl-Moser, R; Dandachi, N; IDENTIFICATION OF PROGNOSTIC METHYLATION MARKERS IN PATIENTS WITH EARLY STAGE COLORECTAL CANCER.
ANN ONCOL. 2012; 23: 87-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Bitsche, S; Osprian, I; Verebes, J; Greimel, A; Schippinger, W; Dandachi, N; Samonigg, H; Heitzer, E; EPCRC Biomarkers as Possible Indicators for Pain Experience ansd Treatment Outcome.
Palliative Medicine. 2012; 26(4):428-429.-7th World Research Congress of the European Association for Palliative Care; JUNE 7-9, 2012; Trondheim, NORWAY. [Oral Communication]

 

Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T; Blood-based treatment monitoring of metastatic colorectal cancer patients by KRAS mutation analysis
Frühjahrstagung der österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2012; Graz. 2012. [Poster]

 

Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T; KRAS mutation analysis using blood derived cell free tumor DNA for treatment monitoring of metastatic colorectal cancer patients
Cancer Res., . 2012; 72: 4513. : -AACR Annual Meeting; MAR 31- APR 4, 2012; Chicago, USA. [Poster]

 

Mohan, S; Auer, M; Heitzer, E; Pichler, M; Geigl, J; Höfler, G; Lax, S; Bauernhofer, T; Riethdorf, S; Pantel, K; Geigl, JB; Speicher, MR. Analysis of Circulating Cell Free Tumor DNA in Plasma in Colon Cancer Patients.
Doctoral day; DEZ 7; Graz, AUSTRIA. 2012. [Poster]

 

Schwerin-Nagel A; Uhrig, S; heitzer E; Wagner K; Gruber-Sedlmayr, U; Lindbichler F; Brunner-Krainz M Bannayan-Riley-Ruvalcaba-Syndrom
Neuropediatrics. 2012; 43(2):-Jahrestagung der Gesellschaft für Neuropädiatrie; April 19-24, 2012; Münster, Germany. [Poster]

 

Thalhammer M; Heitzer E; Liegl-Atzwanger B; Auer M; Speicher MR; Geigl JB SDHB germline mutation in a patient with Carney-Stratakis syndrome.
European Journal of Human Genetics, Suppl. 1. 2012; 20: -European Society of Human Genetics GfH Jahrestagung; June 23-26, 2012; Nürnberg, Germany. [Poster]

 

Deutschmann, A; Heitzer, E; Jahnel, J; Hoffmann, KM; Hauer, A Assoziation einer chronischen Hepatopathie mit einer heterozygoten Mutation im MDR3- sowie einem heterozygoten Polymorphismus im BSEP-Transporter.
Pädiatrie hautnah. 2011; 23(2): (- Case Report) [Poster]
FullText

 

Hofmann, G; Bitsche, S; Osprian, I; Verebes, J; Greimel, A; Schippinger, W; Dandachi, N; Samonigg, H; Heitzer, E Biomarkers as indicators for pain perception and treatment response
3. Österreichischer interdisziplinärer Palliativkongress; DEC 8-10, 2011; Klagenfurt, AUSTRIA. 2011. [Poster]

 

Kroisel, PM, Roetzer, KM; Mach, M; Wagner, K; Speicher, MR; Karpf, EF; Heitzer, E; Häusler, M Arthrogryposis multiplex congenita associated with a heterozygous mutation and 855 kb microduplication in 17q12 both likely affecting function of the cation channel gene ACCN1 in a male fetus.
European Journal of Human Genetics s.u.. 2011; -European Human Genetics Conference 2011; MAY 28 - 31, 2011; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Stadelmeyer, E; Heitzer, E; Resel, M; Cerroni, L; Wolf, P; Dandachi, N Detection of BRAF mutations in lentigo maligna melanoma with a highly sensitive method
Doctoral Day; NOV, 4; Graz, AUSTRIA. 2011. [Poster]

 

Brenne, E; Loge, JH; Heitzer, E; Knudsen, AK; Schippinger, W; Kaasa, S; Wasteson, E. Being depressed in the palliative phase – the patients’ experiences.
Palliat Med 2010. 2010; 24(4):64--6th Research Congress of the European Association for Palliative Care. ; JUN 10-12, 2010; Glasgow, SCOTLAND. [Poster]

 

Heitzer, E; Bambach, I; Dandachi, N; Horn, M; Wolf, P. PTCH Promoter Methylation at Low Level in Sporadic Basal Cell Carcinoma Analyzed by Three Different Approaches
Epigenetics Europe; SEP 14-15,2010; Dublin, IRELAND. 2010. [Poster]
FullText

 

Knudsen, AK; Aass, N; Klepstad, P; Heitzer, E; Hjermstad, MJ; Schippinger, W; Brenne, E; Kaasa, S; Wasteson, E; European Palliative Care Research Collaborative (EPCRC) Advanced cancer patients’ opinion on classification of cancer pain
European Palliative Care Research Collaborative (EPCRC). 2010; -Research Congress of the European Association for Palliative Care; JUN 10-12, 2010; Glasgow, SCOTLAND. [Oral Communication]

 

Knudsen, AK; Aass, N; Klepstad, P; Heitzer, E; Hjermstad, MJ; Schippinger, W; Brenne, E; Kaasa, S; Wasteson, E; European Palliative Care Research Collaborative (EPCRC). Advanced cancer patients¿ opinion on classification of cancer pain.
Palliat Med 2010. 2010; 24(4):25--6th Research Congress of the European Association for Palliative Care; JUN 10-12, 2010; Glasgow, SCOTLAND. [Oral Communication]

 

Knudsen, AK; Aass, N; Klepstad, P; Heitzer, E; Hjermstad, MJ; Schippinger, W; Brenne, E; Kaasa, S; Wasteson, E Advanced cancer patients’ opinion on classification of cancer pain
http://palliative.no/2009; -4th International Trondheim Conference on palliative care; OCT 15-16, 2009; Trondheim, Norway. [Poster]

 

Quehenberger, F; Heitzer, E; Wolf, P Analysis of overdispersion patterns in a study into the monoclonal origin of multiple sporadic basal cell carcinomas.
59th annual Meeting American Society for Human Genetics; OCT 20-24, 2009; Honolulu, Hawaii. 2009. [Poster]
FullText

 

Quehenberger, F; Heitzer, E; Wolf, P Analysis of Overdispersion Patterns in the LOH of Biallelic Markers in a Study into the Polyclonal Origin of Multiple Sporadic Basal Cell Carcinomas.
GENET EPIDEMIOL. 2009; 33(8):228--18th annual meeting of the international genetic epidemiology society; OCT 18-20, 2009; Turtle Bay Resort, Kahuku, USA.. [Poster]
Web of Science

 

Quehenberger, F; Heitzer, E; Wolf P Analysis of overdispersion patterns in the LOH of biallelic markers in a study into the polyclonal origin of multiple sporadic basal cell carcinomas
59th Annual Meeting of the American Society of Human Genetics. 2009; 145-145.-59th Annual Meeting of the American Society of Human Genetics; Oct 20-24; Honolulu, USA. [Poster]

 

Heitzer, E; Lassacher, A; Kerl, H; Wolf, P The UV fingerprint dominates the patched gene mutation spectrum of basal cell carcinoma from different groups, including patients with early-onset and multiple lesions
J INVEST DERMATOL. 126: 76-76. [Poster]
Web of Science

 

Lassacher, A; Heitzer, E; Kerl, H; Wolf, P No major role for p53, RAS, BRAF, INK4a-ARF, and c-kit in merkel cell carcinomas
J INVEST DERMATOL. 126: 77-77. [Poster]
Web of Science

 

Heitzer, E; Lassacher, A; Kerl, H; Wolf, P The UV(B) fingerprint dominates the PTCH mutation spectrum of psoralen plus UVA-associated basal cell carcinomas
J INVEST DERMATOL 2005 125: A56-A56.
Web of Science

 

Lassacher, A; Heitzer, E; Kerl, H; Wolf, P Activating c-Kit exon 11 mutation is absent in Merkel cell carcinoma
J INVEST DERMATOL 2005 125: A64-A64.
Web of Science

 

Worda, M; Kaddu, S; Heitzer, E; Lassacher, A; Baeck, B; Kerl, H; Wolf, P T1796A BRAF mutation is rare inPUVA-associated melanocytic lesions.
Annual ADF (Arbeitsgemeinschaft Dermatologische Forschung) meeting, Innsbruck; MAR 03-05, 2005; Innsbruck, AUSTRIA. 2005. [Poster]

 

Wolf, P; Heitzer, E; Lassacher, A; Kreimer-Erlacher, H; Back, B; Cerroni, L; Kerl, H UVB fingerprint mutations at the INK4a-ARF locus in Merkel cell carcinoma
J INVEST DERMATOL 2004 123: 319-319.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum